Results 61 to 70 of about 121,594 (305)
Epstein‐Barr virus (EBV) is an important environmental risk factor in the development of several autoimmune conditions, with the mechanisms still to be fully elucidated.
Ali Afrasiabi +9 more
doaj +1 more source
Chronic active Epstein–Barr virus infection mimicking tuberculosis – A diagnostic enigma
Chronic active EBV infection is a rare disorder prone for misdiagnosis. They present with a wide range of symptoms from indolent to aggressive clinical course.
Shilpi Thakur +3 more
doaj +1 more source
Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication. [PDF]
EBV has two lytic origins (oriLyt) of DNA replication lying at divergent sites on the viral genome within a duplicated sequence (DS). The latter contains potential hairpin loops, ‘hinge’ elements and the promoters for transcripts from viral genes BHLF1 ...
Xue, SA, Griffin, BE
core
Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim +9 more
wiley +1 more source
EBV-miR-BART1-5P promotes the proliferation of NPC cells.
(A, C) colony formation assay, (B, D) EdU incorporation assays of NPC cells performed after transfection with NC, anti-c, EBV-miR-BART1-5P mimics, inhibitor and/or PTEN plasmid, si-PTEN as indicated. The data were shown as the mean ± s.e.m.
Jianguo Wang (1400488) +17 more
core +1 more source
ABSTRACT As awareness of business–nature interdependencies grows, organizations face increasing demands to assess and manage their nature‐related value chain impacts. Policies, standards, frameworks, and metrics are emerging to support impact measurement, disclosure, and target‐setting.
Brayshna Kundi +2 more
wiley +1 more source
Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting up to 90% of the population. EBV was first identified as an oncogenic virus in a Burkitt lymphoma cell line, though subsequently has been found to drive a variety of malignancies, including ...
Jennifer L. Crombie, Ann S. LaCasce
doaj +1 more source
EBV-miR-BART1-5P enhances glycolysis of NPC cells.
(A) Lactate production, glucose consumption and 2-NBDG uptake (Magnification, ×100) in HONE and CNE1 cells after transfection EBV-miR-BART1-5P mimic alone or co-transfection EBV-miR-BART1-5P mimic and PTEN plasmid.
Jianguo Wang (1400488) +17 more
core +1 more source
Abstract Background Necrotizing periodontal diseases (NPDs) are uncommon and severe inflammatory conditions characterized by tissue necrosis, painful ulceration, and rapid clinical progression, frequently associated with systemic immunosuppression. Limited data exist regarding their clinical presentation and management in hospital settings.
Osmaria Letthycia Carvalho Leal +8 more
wiley +1 more source
Background: Herpes viruses like cytomegalovirus (CMV) and Epstein–Barr virus (EBV) can cause serious illness in those who already have impaired immune systems. Objectives: The purpose of this research was to examine the impact of CMV and EBV infection on
Eman Ammar Ihsan +2 more
doaj +1 more source

